Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2016
CNS accumulation of regulatory B cells is VLA-4-dependentKlaus Lehmann-Horn, Sharon A Sagan, Ryan C Winger, et al.Cold Spring Harbor Perspectives in Medicine|February 15, 2018
The Evolving Mechanisms of Action of Glatiramer AcetateThomas Prod'homme, Scott S ZamvilTrends in Immunology|September 13, 2005
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisLawrence Steinman, Scott S ZamvilNeuron|June 12, 2003
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosisScott S Zamvil, Lawrence SteinmanAnnals of Neurology|June 28, 2006
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisLawrence Steinman, Scott S ZamvilCell|January 23, 2026
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosisLawrence Steinman, Scott S ZamvilCurrent Opinion in Neurology|March 31, 2016
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosisLawrence Steinman, Scott S ZamvilExpert Review of Clinical Pharmacology|June 16, 2012
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosisWolfgang Brück, Scott S ZamvilThe Journal of Clinical Investigation|June 23, 2020
Microglia complement astrocytes in neuromyelitis opticaZahra Moinfar, Scott S ZamvilScience Translational Medicine|October 12, 2018
T cells take aim at a ubiquitous autoantigen in multiple sclerosisJoseph J Sabatino, Scott S ZamvilPageof 18